{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:13:35Z","timestamp":1773224015507,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010600","name":"Tays","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clineuro.2025.109164","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:34:22Z","timestamp":1758090862000},"page":"109164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical characteristics of multiple sclerosis in older adults in a Finnish Tertiary Centre"],"prefix":"10.1016","volume":"258","author":[{"given":"Iiro","family":"Korhonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-9631","authenticated-orcid":false,"given":"Ilkka","family":"Rauma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimi","family":"Ahtinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-4961","authenticated-orcid":false,"given":"Hanna","family":"Kuusisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.109164_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109164_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2025.109164_bib3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2025.109164_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ane.13057","article-title":"Multiple sclerosis epidemiology in Finland: regional differences and high incidence","volume":"139","author":"Pirttisalo","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2025.109164_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7224\/1537-2073.2023-082","article-title":"MyMS: an interface for patient-reported outcomes for Finnish individuals with multiple sclerosis","volume":"26","author":"H\u00e4m\u00e4l\u00e4inen","year":"2024","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.clineuro.2025.109164_bib6","article-title":"Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria\u2014a nationwide population-based registry study over five decades","volume":"11","author":"Maunula","year":"2025","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.clineuro.2025.109164_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.109164_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ane.13145","article-title":"Multiple sclerosis in Finland 2018\u2014data from the national register","volume":"140","author":"Laakso","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2025.109164_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","article-title":"Effect of comorbidity on mortality in multiple sclerosis","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.109164_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102893","article-title":"Immunosenescence in multiple sclerosis: the identification of new therapeutic targets","volume":"20","author":"Dema","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clineuro.2025.109164_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/1352458518765656","article-title":"Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60","volume":"25","author":"Hua","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2025.109164_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7224\/1537-2073.2015-032","article-title":"Stopping Disease-Modifying therapy in nonrelapsing multiple sclerosis","volume":"19","author":"Birnbaum","year":"2017","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.clineuro.2025.109164_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1474-4422(23)00154-0","article-title":"Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial","volume":"22","author":"Corboy","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jamaneurol.2024.4164","article-title":"Discontinuation of first-line disease-modifying therapy in patients with stable multiple sclerosis: the DOT-MS randomized clinical trial","volume":"82","author":"Coerver","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11910-017-0771-9","article-title":"Immunosenescence: the role of aging in the predisposition to neuro-infectious complications arising from the treatment of multiple sclerosis","volume":"17","author":"Grebenciucova","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.clineuro.2025.109164_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1196\/annals.1361.066","article-title":"Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients","volume":"1051","author":"Thewissen","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clineuro.2025.109164_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1234572","article-title":"Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration","volume":"4","author":"Thakolwiboon","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.clineuro.2025.109164_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.109164_bib20","unstructured":"Ministry of Social Affairs and Health, Act on medical research, 2021."},{"key":"10.1016\/j.clineuro.2025.109164_bib21","series-title":"Guidelines in Nonmedical Research","author":"The Finnish National Board on Research Integrity","year":"2019"},{"key":"10.1016\/j.clineuro.2025.109164_bib22","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/ene.13692","article-title":"Early versus later treatment start in multiple sclerosis: a register-based cohort study","volume":"25","author":"Chalmer","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2018.20588","article-title":"Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis","volume":"321","author":"Brown","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109164_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fneur.2017.00577","article-title":"Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments","volume":"8","author":"Weideman","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-023-12041-1","article-title":"Multiple sclerosis in the elderly: a retrospective cohort study","volume":"271","author":"Zinganell","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.24747","article-title":"Long-term evolution of multiple sclerosis disability in the treatment era","volume":"80","author":"University of California, San Francisco MS-EPIC Team","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000109260","article-title":"Multiple sclerosis: relapses and timing of remissions","volume":"59","author":"Iuliano","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.clineuro.2025.109164_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/jnnp.2008.145805","article-title":"Relapses in multiple sclerosis are age- and time-dependent","volume":"79","author":"Tremlett","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:14:56Z","timestamp":1773148496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725004470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0303846725004470"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109164","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of multiple sclerosis in older adults in a Finnish Tertiary Centre","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109164"}}